Comfort Systems USA Inc vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Comfort Systems USA Inc trades at $1,723.29 (market cap $60.06B), while Nuvation Bio Inc. Class A Common Stock trades at $5.01 (market cap $1.74B). The key difference: Comfort Systems USA Inc is far larger — about 34.5× Nuvation Bio Inc. Class A Common Stock's market cap, and Comfort Systems USA Inc pays a 0.21% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Comfort Systems USA Inc for 41 Days and Nuvation Bio Inc. Class A Common Stock for 1 Days on average.
| FIX | NUVB | |
|---|---|---|
Market Cap | $60.06B | $1.74B |
Volume | 371,896 | 9,289,619 |
Sector | Industrials | Health |
52-Week High | $2.07K | $9.54 |
52-Week Low | $790.72 | $3.41 |
Typical Hold Time | 41 Days | 1 Days |
Enterprise Value | $58.53B | $1.33B |
Dividend Yield | 0.21% | — |
Signals from Pluang's Aura AI — not financial advice
Comfort Systems USA (FIX) trades at $1,723.89, down 1.0% on the day, with a bullish technical signal from moving averages. The company demonstrates strong fundamentals with Q2 2026 EPS beating expectations at $12.53 vs. $10.45, and robust profitability metrics including 55.29% ROE. Recent acquisition of Hunt Electric adds $250M in annualized revenue, positioning FIX to capitalize on data center and infrastructure growth trends.
Outlook remains positive with 55.6% analyst buy ratings and $2,080 consensus price target offering 20% upside. Key risks include execution challenges from rapid growth and sensitivity to construction cycle fluctuations. The company's exposure to AI infrastructure and strong backlog provide growth catalysts, though valuation multiples remain elevated at 42x P/E.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Comfort Systems USA is a premier provider of mechanical and electrical contracting services. It specializes in HVAC, plumbing, and energy management solutions for commercial and industrial facilities.
Read more on FIX →Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →